Chemotherapy plus apatinib
REPACC-1
Phase 2 small_molecule completed
Quick answer
Chemotherapy plus apatinib for Recurrent Cervical Carcinoma is a Phase 2 program (small_molecule) at Lei Li with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lei Li
- Indication
- Recurrent Cervical Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed